Research Article
Rapid Screening and Quantitative Determination of Illegal Phosphodiesterase Type 5 Inhibitors (PDE-5i) in Herbal Dietary Supplements
Table 3
Concentration of PDE-5i detected in real samples.
| Sample | PDE-5i | Concentration (mg/g) |
| S 1 | Nortadalafil | 50.0 ± 0.13 | Tadalafil | 11.6 ± 0.05 | Sildenafil-N-oxide | ∼0.073 | S 2 | Nortadalafil | 4.41 ± 0.05 | Chloropretadalafil | ∼0.006 | S 3 | Sildenafil | 22.2 ± 0.11 | Tadalafil | 0.39 ± 0.007 | Sildenafil-N-oxide | ∼0.06 | S 4 | Propoxyphenylaildenafil | 1.02 ± 0.06 | Thiohomosildenafil | 0.78 ± 0.005 | Homosildenafil | ∼0.031 | Methisosildenafil | ∼0.03 | S 5–9 | Hydroxyhomosildenafil | 1.05–20.1 | Hydroxythiohomosildenafil | 0.78–22.5 | S 10 | Tadalafil | ∼0.08 | S 11 | Tadalafil | 10.2 ± 0.05 | Chloropretadalafil | 5.25 ± 0.06 | S 12 | Nortadalafil | 12.2 ± 0.05 | Chloropretadalafil | 0.25 ± 0.06 | S 13 | Nortadalafil | 10.2 ± 0.04 | Chloropretadalafil | 5.25 ± 0.10 | S 14 | Acetil acid | 0.13 ± 0.06 | S 15 | Tadalafil | 0.12 ± 0.05 | S 16 | Sildenafil | 5.25 ± 0.11 | Tadalafil | 4.77 ± 0.15 | Aminotadalafil | 0.52 ± 0.05 | Sildenafil N-oxyde | 0.56 ± 0.06 | S 17 | Nortadalafil | 0.52 ± 0.06 | Chloropretadalafil | 4.77 ± 0.10 | S 18 | Nortadalafil | 12.1 ± 0.06 | M 1 | Nortadalafil | 170.0 ± 1.22 | M 2 | Hydroxythiohomosildenafil | 226.8 ± 1.36 | Hydroxythiovardenafil | 216.8 ± 2.00 | Propoxyphenyl-homohydroxysildenafil | 0.13 ± 0.06 | Hydroxyhomo-sildenafil | ∼0.048 | Hydroxyvardenafil | ∼0.047 |
|
|
S: supplementary food, M: medicine ingredient, “S 5–9” indicates samples: S 5, S 6, S 7, S 8, S 9.
|